Sitian Wei

756 total citations · 1 hit paper
24 papers, 511 citations indexed

About

Sitian Wei is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Sitian Wei has authored 24 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Obstetrics and Gynecology. Recurrent topics in Sitian Wei's work include Endometrial and Cervical Cancer Treatments (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (5 papers). Sitian Wei is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (5 papers). Sitian Wei collaborates with scholars based in China, United Kingdom and Belarus. Sitian Wei's co-authors include Hongbo Wang, Rui Shi, Jun Zhang, Zhicheng Yu, Dilu Feng, Qi Zhang, Jun Zhang, Shan‐Shan Rao, Qian Li and Rong Zhao and has published in prestigious journals such as ACS Nano, Chemical Engineering Journal and Journal of Medicinal Chemistry.

In The Last Decade

Sitian Wei

23 papers receiving 507 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma

2024 63 citations Sitian Wei, Jun Zhang et al. Cell Death Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sitian Wei China	12	302	208	108	86	78	24	511
Haifeng Liang China	11	432 1.4×	317 1.5×	67 0.6×	85 1.0×	95 1.2×	28	628
Lingxiong Wang China	14	296 1.0×	170 0.8×	148 1.4×	151 1.8×	95 1.2×	29	670
Xiumei Ma China	12	181 0.6×	108 0.5×	110 1.0×	76 0.9×	110 1.4×	34	473
Fanqin Bu China	13	252 0.8×	132 0.6×	75 0.7×	41 0.5×	50 0.6×	28	393
Fengyan Han China	12	363 1.2×	246 1.2×	78 0.7×	49 0.6×	36 0.5×	24	536
Yongbin Zheng China	12	204 0.7×	171 0.8×	80 0.7×	44 0.5×	38 0.5×	33	471
Jianwei Zhu China	15	322 1.1×	187 0.9×	111 1.0×	32 0.4×	43 0.6×	58	606
Guanglei Qiao China	14	444 1.5×	224 1.1×	77 0.7×	63 0.7×	158 2.0×	28	651
América Campos Chile	13	400 1.3×	227 1.1×	26 0.2×	65 0.8×	61 0.8×	17	502
Zhiwei Peng China	10	153 0.5×	96 0.5×	53 0.5×	72 0.8×	50 0.6×	32	338

Countries citing papers authored by Sitian Wei

Since Specialization

Citations

This map shows the geographic impact of Sitian Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sitian Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sitian Wei more than expected).

Fields of papers citing papers by Sitian Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sitian Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sitian Wei. The network helps show where Sitian Wei may publish in the future.

Co-authorship network of co-authors of Sitian Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Sitian Wei. A scholar is included among the top collaborators of Sitian Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sitian Wei. Sitian Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hongbo, Zhicheng Yu, Sitian Wei, et al.. (2024). The vasculogenic mimicry, CD146 ⁺ and CD105 ⁺ microvessel density in the prognosis of endometrioid endometrial adenocarcinoma: a single-centre immunohistochemical study. Biomarkers. 29(7). 459–465.

Zhang, Qi, Zhicheng Yu, Ting Zhou, et al.. (2024). Bioinformatics Analysis and Experimental Verification Define Different Angiogenesis Subtypes in Endometrial Carcinoma and Identify a Prognostic Signature. ACS Omega. 9(24). 26519–26539. 2 indexed citations

Shi, Rui, Rong Zhao, Yan Shen, et al.. (2024). IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway. Cancer Gene Therapy. 31(8). 1221–1236. 10 indexed citations

Wei, Sitian, Jun Zhang, Rong Zhao, et al.. (2024). Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma. Cell Death Discovery. 10(1). 121–121. 63 indexed citations breakdown →

Yu, Zhicheng, Qian Zhang, Sitian Wei, et al.. (2024). CD146+CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10/JAK1/STAT3 pathway. Cell Communication and Signaling. 22(1). 170–170. 20 indexed citations

Zhang, Qi, Sitian Wei, Ting Zhou, et al.. (2024). Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma. Translational Cancer Research. 13(6). 2913–2937. 2 indexed citations

Zhang, Jun, Ting Zhou, Shan‐Shan Rao, et al.. (2023). Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA. Redox Biology. 69. 102975–102975. 61 indexed citations

Dong, Kejun, Shuqi Chi, Sitian Wei, et al.. (2023). lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer. Molecular Carcinogenesis. 63(3). 384–399. 6 indexed citations

Zhang, Qian, Jun Zhang, Rong Zhao, et al.. (2023). Identification of the role of endoplasmic reticulum stress genes in endometrial cancer and their association with tumor immunity. BMC Medical Genomics. 16(1). 261–261. 7 indexed citations

10.

Shi, Rui, Sitian Wei, Zhicheng Yu, et al.. (2023). Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer. BMC Cancer. 23(1). 491–491. 7 indexed citations

11.

Wei, Sitian, Zhicheng Yu, Rui Shi, et al.. (2022). GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1. BMC Cancer. 22(1). 881–881. 30 indexed citations

12.

Wei, Sitian, Jun Zhang, Rui Shi, et al.. (2022). Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma. Frontiers in Oncology. 12. 944000–944000. 5 indexed citations

13.

Zhou, Xing, Sitian Wei, Jun Zhang, et al.. (2022). Laparoscopic vs. open procedure for intermediate‑ and high‑risk endometrial cancer: a minimum 4-year follow-up analysis. BMC Cancer. 22(1). 1203–1203. 5 indexed citations

14.

Zhang, Jun, Sitian Wei, Shuangshuang Cheng, et al.. (2022). CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biology. 57. 102493–102493. 53 indexed citations

15.

Feng, Dilu, et al.. (2022). Human papillomavirus prevalence and genotype distribution landscapes in Shannan City, Tibet Tibetan Autonomous Region, China. Virology Journal. 19(1). 46–46. 10 indexed citations

16.

Song, Wen, Shujun Song, Jing Kuang, et al.. (2022). Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy. ACS Nano. 16(10). 15977–15993. 58 indexed citations

17.

Luo, Yue, Jun Zhang, Rui Shi, et al.. (2022). The highly effective therapy of ovarian cancer by Bismuth-doped oxygen-deficient BaTiO3 with enhanced sono-piezocatalytic effects. Chemical Engineering Journal. 442. 136380–136380. 54 indexed citations

18.

Zhang, Jun, Dilu Feng, Yingchao Zhao, et al.. (2021). KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer. Stem Cells International. 2021. 1–13. 27 indexed citations

19.

Shi, Rui, Ziwei Wang, Jun Zhang, et al.. (2021). N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer. International Journal of General Medicine. Volume 14. 8249–8262. 11 indexed citations

20.

Yu, Zhicheng, Sitian Wei, Jun Zhang, et al.. (2021). Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics. Cancer Management and Research. Volume 13. 8879–8886. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact